Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will present at the International Association for Chemical Testing (IACT) conference. Cannabix’s Dr. Bruce Goldberger, a UF professor, will present on Science & Technology Behind Cannabis Breath Testing and the company’s marijuana breathalyzer system at the conference workshop session.
Where Will Artificial Intelligence Take the Produce Industry?
Yiannis Ampatzidis, a University of Florida’s Institute of Food and Agricultural Sciences associate professor of agricultural and biological engineering, calls AI the fourth agri-revolution. Ampatzidis, who studies precision agriculture and mechanization for crop production, has seen firsthand the importance — and potential — of AI.
University of Florida Scientist to Fly on Blue Origin Suborbital Mission
University of Florida Distinguished Professor Rob Ferl will be the first NASA-funded academic researcher to conduct an experiment as part of a commercial space crew on an upcoming mission of Blue Origin’s New Shepard rocket.
American Association for the Advancement of Science Honors 12 UF Faculty As Lifetime Fellows
The American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals, has elected 12 faculty from the University of Florida to its newest class.
Yikes! Scientists Discover Factor That Directs Brain’s Fear Conditioning
A team led by neuroscientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology has discovered a key molecular player in fear conditioning. It’s a specialized RNA with a memorable acronym, SLAMR. Their study found SLAMR must be present in adequate quantities for neurons to build the complex connections required for fear conditioning. Their research appears in the journal Nature Communications.
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix
UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath-testing devices reports that it has shipped its Industrial Series Contactless Alcohol Breathalyzers (“CAB” devices) for certification testing and is rebranding the “CAB” name under the new “Breath Logix” product series, part of the company’s portfolio of marijuana and alcohol screening devices.
Researchers Create a New AI Pipeline for Identifying Molecular Interactions
Understanding how proteins interact with each other is crucial for developing new treatments and understanding diseases. Thanks to computational advances, a team of researchers led by Assistant Professor of Chemistry Alberto Perez have developed a groundbreaking algorithm to identify these molecular interactions.
Agriculture Intelligence to Feature in the 2024 AI in AG Conference at Texas A&M University
Agriculture Intelligence, a leader in agricultural science technology, is proud to announce its participation in the upcoming AI in AG conference, scheduled for April 15-17 at Texas A&M University. The conference will gather experts and leaders from across the industry to discuss the integration of advanced technologies in agriculture.
Fang Invited to Present at the National Academies’ Workshop on Bidirectionality Between AI & Neuroscience
UF researcher Dr. Ruogu Fang was invited to present at The National Academies’ Workshop on Bidirectionality between AI and Neuroscience. The invitation comes from The National Academies Forum on Neuroscience and Nervous System Disorders, organizing a hybrid workshop titled “Exploring the Bidirectional Relationship between Artificial Intelligence and Neuroscience.” The workshop occurred on March 25-26 in Washington, D.C.
UF-Led Researchers Link New Genetic Mutation to Increased Risk of Parkinson’s
New research by a University of Florida-led international team has revealed evidence linking a new genetic mutation to greater risk of developing Parkinson’s disease.
